141 related articles for article (PubMed ID: 24420714)
1. Bioactive poly(arsenic) compounds.
Mancini I; Defant A
Prog Mol Subcell Biol; 2013; 54():175-95. PubMed ID: 24420714
[TBL] [Abstract][Full Text] [Related]
2. Mineral arsenicals in traditional medicines: orpiment, realgar, and arsenolite.
Liu J; Lu Y; Wu Q; Goyer RA; Waalkes MP
J Pharmacol Exp Ther; 2008 Aug; 326(2):363-8. PubMed ID: 18463319
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide in the management of acute promyelocytic leukaemia.
Mathews V; Chandy M; Srivastava A
Natl Med J India; 2001; 14(4):215-22. PubMed ID: 11547528
[TBL] [Abstract][Full Text] [Related]
4. The medicinal use of realgar (As₄S₄) and its recent development as an anticancer agent.
Wu J; Shao Y; Liu J; Chen G; Ho PC
J Ethnopharmacol; 2011 Jun; 135(3):595-602. PubMed ID: 21497649
[TBL] [Abstract][Full Text] [Related]
5. Inhibition factors of arsenic trioxide therapeutic effects in patients with acute promyelocytic leukemia.
Sui M; Zhang Z; Zhou J
Chin Med J (Engl); 2014; 127(19):3503-6. PubMed ID: 25269921
[TBL] [Abstract][Full Text] [Related]
6. Arsenic compounds: revived ancient remedies in the fight against human malignancies.
Liu JX; Zhou GB; Chen SJ; Chen Z
Curr Opin Chem Biol; 2012 Apr; 16(1-2):92-8. PubMed ID: 22342767
[TBL] [Abstract][Full Text] [Related]
7. Arsenic derivatives in hematologic malignancies: a role beyond acute promyelocytic leukemia?
Verstovsek S; Giles F; Quintás-Cardama A; Perez N; Ravandi-Kashani F; Beran M; Freireich E; Kantarjian H
Hematol Oncol; 2006 Dec; 24(4):181-8. PubMed ID: 16783836
[TBL] [Abstract][Full Text] [Related]
8. Arsenic in medicine: past, present and future.
Paul NP; Galván AE; Yoshinaga-Sakurai K; Rosen BP; Yoshinaga M
Biometals; 2023 Apr; 36(2):283-301. PubMed ID: 35190937
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies.
Douer D; Tallman MS
J Clin Oncol; 2005 Apr; 23(10):2396-410. PubMed ID: 15800332
[TBL] [Abstract][Full Text] [Related]
10. [Research advances on effect of arsenic trioxide on tumor].
Feng CQ; Ma WL; Zheng WL
Ai Zheng; 2002 Dec; 21(12):1386-9. PubMed ID: 12520754
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide as first-line treatment for acute promyelocytic leukemia.
Leu L; Mohassel L
Am J Health Syst Pharm; 2009 Nov; 66(21):1913-8. PubMed ID: 19850784
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acute promyelocytic leukemia with arsenic trioxide.
Conrad ME
N Engl J Med; 1999 Apr; 340(13):1043-5. PubMed ID: 10189286
[No Abstract] [Full Text] [Related]
13. Use of arsenic trioxide in a hemodialysis-dependent patient with relapsed acute promyelocytic leukemia.
Perreault S; Moeller J; Patel K; Eyler R; Pham T; Russell K; Podoltsev N
J Oncol Pharm Pract; 2016 Aug; 22(4):646-51. PubMed ID: 25972392
[TBL] [Abstract][Full Text] [Related]
14. Swallowing a bitter pill-oral arsenic trioxide for acute promyelocytic leukemia.
Torka P; Al Ustwani O; Wetzler M; Wang ES; Griffiths EA
Blood Rev; 2016 May; 30(3):201-11. PubMed ID: 26709030
[TBL] [Abstract][Full Text] [Related]
15. Arsenic prepared by Chinese alchemist-pharmacists.
Zhu J; Ren D
Sci China Life Sci; 2016 Oct; 59(10):1086-1089. PubMed ID: 27687865
[No Abstract] [Full Text] [Related]
16. Darinaparsin: a novel organic arsenical with promising anticancer activity.
Mann KK; Wallner B; Lossos IS; Miller WH
Expert Opin Investig Drugs; 2009 Nov; 18(11):1727-34. PubMed ID: 19780704
[TBL] [Abstract][Full Text] [Related]
17. Arsenic sulfide, the main component of realgar, a traditional Chinese medicine, induces apoptosis of gastric cancer cells in vitro and in vivo.
Zhang L; Tian W; Kim S; Ding W; Tong Y; Chen S
Drug Des Devel Ther; 2015; 9():79-92. PubMed ID: 25565771
[TBL] [Abstract][Full Text] [Related]
18. Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent.
Amadori S; Fenaux P; Ludwig H; O'dwyer M; Sanz M
Curr Med Res Opin; 2005 Mar; 21(3):403-11. PubMed ID: 15811209
[TBL] [Abstract][Full Text] [Related]
19. Biological responses to arsenic compounds.
Platanias LC
J Biol Chem; 2009 Jul; 284(28):18583-7. PubMed ID: 19363033
[TBL] [Abstract][Full Text] [Related]
20. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.
Xiao X; Liu Y; Guo M; Fei W; Zheng H; Zhang R; Zhang Y; Wei Y; Zheng G; Li F
J Biomater Appl; 2016 Jul; 31(1):23-35. PubMed ID: 27059495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
